Filed with ASX · · 5 pages · English
Neurizon Therapeutics Limited has submitted an application for the quotation of securities on the ASX, specifically for ordinary fully paid shares. The application includes details of the number of securities to be quoted, which is part of a previously announced transaction. The filing also mentions further issues of securities that are subject to shareholder approval expected in December.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Appendix 2A - Application for quotation of securities Announcement Summary Entity name NEURIZON THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Friday November 06, 2026 The +securities to be quoted are: +Securities issued as part of a transaction or transactions...
Neurizon Therapeutics Limited on 6ix
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics